Pharmaceutical companies in the United States by operating margin
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Royalty Pharma leads the 27 pharmaceutical companies in the United States ranked by operating margin, at 65.6%, ahead of PTC Therapeutics (50.1%) and United Therapeutics (46.9%). Figures as of 20 Nov 2026, 02:02 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 27
- First
- Royalty Pharma65.6%
- Median
- 5.88%
- Combined market value
- CZK 83.23T
- Countries
- 1
- Not ranked
- 17no operating margin on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Operating margin ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Royalty PharmaRPRX · Health Care | 65.6% | CZK 867.5B | CZK 1,508.67 | 1.38% down | 79% up | ||
| 2 | PTC TherapeuticsPTCT · Health Care | 50.1% | CZK 108.6B | CZK 1,299.36 | 3.16% down | 21% down | ||
| 3 | United TherapeuticsUTHR · Health Care | 46.9% | CZK 530.5B | CZK 12,455.63 | 3.16% down | 22% up | ||
| 4 | Vertex PharmaceuticalsVRTX · Health Care | 34.8% | CZK 2.94T | CZK 11,599.26 | 2.94% down | 27% up | ||
| 5 | Regeneron PharmaceuticalsREGN · Health Care | 24.9% | CZK 2.13T | CZK 20,570.17 | 2.35% down | 28% up | ||
| 6 | AbbVieABBV · Health Care | 24.6% | CZK 11.17T | CZK 6,316.70 | 0.86% down | 25% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | 20.0% | CZK 218.5B | CZK 1,445.40 | 1.88% down | 117% up | ||
| 8 | Abbott LaboratoriesABT · Health Care | 18.2% | CZK 4.01T | CZK 2,314.02 | 0.58% down | 16% down | ||
| 9 | Ligand PharmaceuticalsLGND · Health Care | 15.3% | CZK 127.9B | CZK 6,392.45 | 3.94% down | 50% up | ||
| 10 | Alnylam PharmaceuticalsALNY · Health Care | 13.5% | CZK 441.1B | CZK 3,293.13 | 1.06% down | 66% down | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | 13.1% | CZK 166B | CZK 476.53 | 2.24% down | 90% up | ||
| 12 | BioMarin PharmaceuticalBMRN · Health Care | 12.7% | CZK 265B | CZK 1,368.31 | 0.02% down | 17% up | ||
| 13 | Arrowhead PharmaceuticalsARWR · Health Care | 11.9% | CZK 137.5B | CZK 972.43 | 1.25% up | 13% up | ||
| 14 | Corcept TherapeuticsCORT · Health Care | 5.88% | CZK 158.4B | CZK 1,447.62 | 4.15% down | 10% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | -4.25% | CZK 138.9B | CZK 2,127.77 | 3.27% up | 34% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | -12.8% | CZK 103.3B | CZK 1,076.03 | 3.86% down | 45% up | ||
| 17 | Legend BiotechLEGN · Health Care | -13.3% | CZK 69.6B | CZK 358.68 | 0.92% down | 41% down | ||
| 18 | ViatrisVTRS · Health Care | -18.6% | CZK 507.7B | CZK 442.89 | 1.97% down | 99% up | ||
| 19 | Axsome TherapeuticsAXSM · Health Care | -26.1% | CZK 159B | CZK 3,022.68 | 1.25% up | 6% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | -31.3% | CZK 205.3B | CZK 8,838.57 | 0.34% down | 27% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | -40.4% | CZK 101B | CZK 606.41 | 0.62% down | 63% down | ||
| 22 | Rhythm PharmaceuticalsRYTM · Health Care | -101% | CZK 180.4B | CZK 2,602.07 | 1.88% down | 18% up | ||
| 23 | BridgeBio PharmaBBIO · Health Care | -104% | CZK 339.3B | CZK 1,741.69 | 0.22% up | 21% up | ||
| 24 | InsmedINSM · Health Care | -206% | CZK 706B | CZK 3,218.28 | 20.58% up | 40% down | ||
| 25 | Protagonist TherapeuticsPTGX · Health Care | -344% | CZK 180.3B | CZK 2,762.92 | 2.47% down | 51% up | ||
| 26 | CytokineticsCYTK · Health Care | -695% | CZK 159.7B | CZK 1,146.43 | 0.27% up | 19% down | ||
| 27 | Dianthus TherapeuticsDNTH · Health Care | -8739% | CZK 106.4B | CZK 1,889.84 | 1.01% up | 108% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Operating margin is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Banks and insurers report no operating income and are not ranked on it. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2780 CZK). 17 companies have no operating margin on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by operating margin?
Royalty Pharma (65.6%), PTC Therapeutics (50.1%) and United Therapeutics (46.9%) are the top three of the 27 pharmaceutical companies in the United States ranked by operating margin as of 20 Nov 2026, 02:02 UTC.
How many pharmaceutical companies in the United States are in this ranking?
27 are ranked by operating margin. 17 more have no operating margin on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 27 pharmaceutical companies in the United States ranked by operating margin have a combined market value of CZK 83.23T as of 20 Nov 2026, 02:02 UTC.
What does ranking by operating margin measure?
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by operating margin”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=operating-margin
Underlying data: Yahoo Finance; SEC EDGAR.